Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility of the LUM Imaging System for Detection of Prostate Cancer

NCT03441464 is registered in ClinicalTrials.gov with Lumicell, Inc. as lead sponsor.

NCT NCT03441464
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03441464 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility of the LUM Imaging System for Detection of Prostate Cancer
Lead sponsor
Lumicell, Inc.
Phase
Phase 1/2
Overall status
Terminated
Start date
March 20, 2019
Completion date
February 11, 2021
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neoplasm, residual, prostate cancer